Clinical Trial Update: A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 multiple ascending dose study in adults with hypercholesterolemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HTD1801

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: Hypercholesterolemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-03